These findings suggested that olanzapine-induced increase in hypothalamic astrocytes and activation of TLR4 signaling were related to ER stress, and these effects may be related to olanzapine-induced obesity. The gene discussed is TLR4; the disease is obesity due to melanocortin 4 receptor deficiency.